These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 6231484)

  • 1. Genetically restricted antigen presentation for immunological tolerance and suppression.
    Lowy A; Drebin JA; Monroe JG; Granstein RD; Greene MI
    Nature; 1984 Mar 22-28; 308(5957):373-5. PubMed ID: 6231484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tolerance induction of allo-class II H-2 antigen-reactive L3T4+ helper T cells and prolonged survival of the corresponding class II H-2-disparate skin graft.
    Hori S; Sato S; Kitagawa S; Azuma T; Kokudo S; Hamaoka T; Fujiwara H
    J Immunol; 1989 Sep; 143(5):1447-52. PubMed ID: 2527264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunoregulatory pathways in adult responder mice. III. Establishment of a GAT-specific suppressor T cell clone from GAT-tolerant responders which afferently regulates DTH responses.
    Jenkins MK; Miller SD
    J Mol Cell Immunol; 1985; 2(1):1-13. PubMed ID: 2978221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective reversal of H-2-linked genetic unresponsiveness to lysozymes. II. Alteration in the T helper/T suppressor balance, owing to gene(s) linked to Ir-2, leads to responsiveness in BALB.B.
    Sadegh-Nasseri S; Dessi V; Sercarz EE
    Eur J Immunol; 1986 May; 16(5):486-92. PubMed ID: 2938974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of transplantation immunity in vivo by monoclonal antibodies recognizing host class II restriction elements. II. Effects of anti-Ia immunotherapy on host T cell responses to graft alloantigens.
    Williams IR; Perry LL
    J Immunol; 1985 May; 134(5):2942-7. PubMed ID: 3156920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T cell tolerization in vitro: modulation of helper and suppressor cell activities.
    Bleux C; Liacopoulos P; Couderc J; Kanellopoulos-Langevin C
    J Immunol; 1987 Jul; 139(2):338-45. PubMed ID: 2439586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo effects of GK1.5 (anti-L3T4a) monoclonal antibody on induction and expression of delayed-type hypersensitivity.
    Miller SD; Jenkins MK
    Cell Immunol; 1985 May; 92(2):414-26. PubMed ID: 2859929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro analysis of allogeneic lymphocyte interaction. VI. I-J-restricted self-reactive and alloreactive components of allogeneic effect factor (AEF) are distinct I-J- molecules that interact with I-J+ T cells and antigen-presenting cells.
    Delovitch TL; Kaufman K; Gorczynski RM
    J Immunol; 1983 May; 130(5):2241-9. PubMed ID: 6220086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of delayed-type hypersensitivity. VI. Antigen-specific suppressor T cells and suppressor factor for delayed-type hypersensitivity to histocompatibility antigens.
    Liew FY
    Transplantation; 1982 Jan; 33(1):69-76. PubMed ID: 6461112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Infectious and noninfectious tolerance are blocked by a monoclonal antibody to T-suppressor factor.
    Ferguson TA; Iverson GM; Flood PM
    Cell Immunol; 1988 Sep; 115(2):403-12. PubMed ID: 2970308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinct subsets of accessory cells activate Thy-1+ triple negative (CD3-, CD4-, CD8-) cells and Th-1 delayed-type hypersensitivity effector T cells.
    Matsushima GK; Stohlman SA
    J Immunol; 1991 May; 146(10):3322-31. PubMed ID: 1673982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T cell responses induced by the parenteral injection of antigen-modified syngeneic cells. I. Induction, characterization, and regulation of antigen-specific T helper cells involved in delayed-type hypersensitivity responses.
    Miller SD; Butler LD
    J Immunol; 1983 Jul; 131(1):77-85. PubMed ID: 6190929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression of delayed-type hypersensitivity to third party "bystander" alloantigens by antigen-specific suppressor T cells.
    Bianchi AT; Hussaarts-Odijk LM; Benner R
    Cell Immunol; 1983 Oct; 81(2):333-44. PubMed ID: 6227391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A helper T cell clone produces an antigen-specific molecule (T-ABM) which functions in the induction of suppression.
    Green DR; Chue B; Zheng HG; Ferguson TA; Beaman KD; Flood PM
    J Mol Cell Immunol; 1987; 3(2):95-108. PubMed ID: 2978240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional analysis of cloned macrophage hybridomas. VI. Differential ability to induce immunity or suppression.
    Kuchroo VK; Minami M; Diamond B; Dorf ME
    J Immunol; 1988 Jul; 141(1):10-6. PubMed ID: 2454255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antigen presentation by Langerhans cells in vivo: donor-derived Ia+ Langerhans cells are required for induction of delayed-type hypersensitivity but not for cytotoxic T lymphocyte responses to alloantigens.
    Peeler JS; Niederkorn JY
    J Immunol; 1986 Jun; 136(12):4362-71. PubMed ID: 3519767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of two distinct primary T cell populations that secrete interleukin 2 upon recognition of class I or class II major histocompatibility antigens.
    Mizuochi T; Ono S; Malek TR; Singer A
    J Exp Med; 1986 Mar; 163(3):603-19. PubMed ID: 2936862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppressor T cells, antigen-presenting cells and the role of I-J restriction in oral tolerance to ovalbumin.
    Mowat AM; Lamont AG; Parrott DM
    Immunology; 1988 May; 64(1):141-5. PubMed ID: 2968305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A cascade of T-T interactions, mediated by the linked recognition of antigen, in the induction of T cells able to help delayed-type hypersensitivity responses.
    Bretscher PA
    J Immunol; 1986 Dec; 137(12):3726-33. PubMed ID: 2431041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The ability of Ia and H-2Kk-bearing membranes to replace the antigen-presenting cell in an H-2Kk allogeneic cytotoxic T cell response.
    Weinberger O; Herrmann SH; Greenstein JL; Mescher MF; Burakoff SJ
    Eur J Immunol; 1985 Oct; 15(10):1013-8. PubMed ID: 2932336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.